Keywords: Cancer, Prostate, Spectroscopy
HRMAS 1H MRS was employed for an untargeted investigation of metabolism in prostate cancer patients on AS (n=52). Serum samples from two matched patient groups, progressive (n=26) and non-progressive (n=26) were measured with short and long T2 filter to investigate metabolites in the lipoprotein and LMWM regions respectively. PCA on 46 ROI from data acquired by HRMAS 1H MRS with short T2 resulted in a metabolomic profile, PC7, that separated the progressive and non-progressive groups (p = 0.0323). The findings of such studies could revolutionize healthcare by improving the diagnosis of diseases and contributing to multi-omics integration for precision medicine.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords